MAESTRO RECHARGEABLE SYSTEM

Neuromodulator For Obesity

FDA Premarket Approval P130019

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the maestro® rechargeable system. This device is indicated for use in weight reduction in patients aged 18 years through adulthood who have a body mass index (bmi) of 40 to 45 kg/m2, or a bmi of 35 to 39. 9 kg/m2 with one or more obesity related co-morbid conditions, and have failed at least one supervised weight management program within the past five years.

DeviceMAESTRO RECHARGEABLE SYSTEM
Classification NameNeuromodulator For Obesity
Generic NameNeuromodulator For Obesity
ApplicantReShape Lifesciences, Inc.
Date Received2013-06-21
Decision Date2015-01-14
Notice Date2015-01-16
PMAP130019
SupplementS
Product CodePIM
Docket Number15M-0201
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address ReShape Lifesciences, Inc. 2800 Patton Road saint Paul, MN 55113
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P130019Original Filing
S019 2018-12-17 Normal 180 Day Track No User Fee
S018 2018-02-12 Real-time Process
S017 2018-02-09 Real-time Process
S016 2017-12-28 30-day Notice
S015 2017-06-08 Normal 180 Day Track No User Fee
S014 2017-04-28 Real-time Process
S013 2017-03-02 Special (immediate Track)
S012 2016-12-08 Special (immediate Track)
S011 2016-09-29 Real-time Process
S010 2016-08-26 30-day Notice
S009 2016-06-07 Normal 180 Day Track No User Fee
S008 2016-05-13 30-day Notice
S007 2016-01-20 30-day Notice
S006 2015-03-25 Real-time Process
S005 2015-03-24 Real-time Process
S004 2015-03-23 30-day Notice
S003 2015-03-20 30-day Notice
S002 2015-02-27 Normal 180 Day Track No User Fee
S001 2015-02-26 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00857334004361 P130019 000
00857334004200 P130019 000
00857334004217 P130019 000
00857334004248 P130019 000
00857334004262 P130019 000
00857334004279 P130019 000
00857334004286 P130019 000
00857334004293 P130019 000
00857334004309 P130019 000
00857334004316 P130019 000
00857334004323 P130019 000
00857334004347 P130019 000
00857334004354 P130019 000
00857334004194 P130019 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.